Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

TGTX TG Therapeutics, Inc.
$50.02 0.28% +0.14
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TGTX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 7.6B
Enterprise value 7.3B
Trailing PE 17.814287
Forward PE 16.10201
PEG Ratio -0.24176532357143
Enterprise to EBITDA 53.568
Enterprise to revenue 9.141
Price to book MRQ 12.124454
Price to sales TTM 9.550301

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 799.5M
EBITDA 134.4M
Diluted EPS TTM 2.8
Total Cash (MRQ) 514.4M
Current ratio (MRQ) 5.8093133377515
Operating Cash Flow (TTM) -24772000

TGTX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent TGTX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.